BIOMAT Database Logo BIOMAT Database Logo

Effect of viral suppression on hepatic venous pressure gradient in hepatitis C with cirrhosis and portal hypertension. 2017

N Afdhal, and G T Everson, and J L Calleja, and G W McCaughan, and J Bosch, and D M Brainard, and J G McHutchison, and S De-Oertel, and D An, and M Charlton, and K R Reddy, and T Asselah, and E Gane, and M P Curry, and X Forns
Beth Israel Deaconess Medical Center, Boston, Massachusetts, USA.

Portal hypertension is a predictor of liver-related clinical events and mortality in patients with hepatitis C and cirrhosis. The effect of interferon-free hepatitis C treatment on portal pressure is unknown. Fifty patients with Child-Pugh-Turcotte (CPT) A and B cirrhosis and portal hypertension (hepatic venous pressure gradient [HVPG] >6 mm Hg) were randomized to receive 48 weeks of open-label sofosbuvir plus ribavirin at Day 1 or after a 24-week observation period. The primary endpoint was sustained virologic response 12 weeks after therapy (SVR12) in patients who received ≥1 dose of treatment. Secondary endpoints included changes in HVPG, laboratory parameters, and MELD and CPT scores. A subset of patients was followed 48 weeks posttreatment to determine late changes in HVPG. SVR12 occurred in 72% of patients (33/46). In the 37 patients with paired HVPG measurements at baseline and the end of treatment, mean HVPG decreased by -1.0 (SD 3.97) mm Hg. Nine patients (24%) had ≥20% decreases in HVPG during treatment. Among 39 patients with pretreatment HVPG ≥12 mm Hg, 27 (69%) achieved SVR12. Four of the 33 (12%) patients with baseline HVPG ≥12 mm Hg had HVPG <12 mm Hg at the end of treatment. Of nine patients with pretreatment HVPG ≥12 mm Hg who achieved SVR12 and completed 48 weeks of follow-up, eight (89%) had a ≥20% reduction in HVPG, and three reduced their pressure to <12 mm Hg. Patients with chronic HCV and compensated or decompensated cirrhosis who achieve SVR can have clinically meaningful reductions in HVPG at long-term follow-up. (EudraCT 2012-002457-29).

UI MeSH Term Description Entries
D006975 Hypertension, Portal Abnormal increase of resistance to blood flow within the hepatic PORTAL SYSTEM, frequently seen in LIVER CIRRHOSIS and conditions with obstruction of the PORTAL VEIN. Cruveilhier-Baumgarten Disease,Cruveilhier-Baumgarten Syndrome,Cruveilhier Baumgarten Disease,Cruveilhier Baumgarten Syndrome,Disease, Cruveilhier-Baumgarten,Portal Hypertension,Portal Hypertensions,Syndrome, Cruveilhier-Baumgarten
D008103 Liver Cirrhosis Liver disease in which the normal microcirculation, the gross vascular anatomy, and the hepatic architecture have been variably destroyed and altered with fibrous septa surrounding regenerated or regenerating parenchymal nodules. Cirrhosis, Liver,Fibrosis, Liver,Hepatic Cirrhosis,Liver Fibrosis,Cirrhosis, Hepatic
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D004359 Drug Therapy, Combination Therapy with two or more separate preparations given for a combined effect. Combination Chemotherapy,Polychemotherapy,Chemotherapy, Combination,Combination Drug Therapy,Drug Polytherapy,Therapy, Combination Drug,Chemotherapies, Combination,Combination Chemotherapies,Combination Drug Therapies,Drug Polytherapies,Drug Therapies, Combination,Polychemotherapies,Polytherapies, Drug,Polytherapy, Drug,Therapies, Combination Drug
D005260 Female Females
D005838 Genotype The genetic constitution of the individual, comprising the ALLELES present at each GENETIC LOCUS. Genogroup,Genogroups,Genotypes
D006503 Hepatic Veins Veins which drain the liver. Hepatic Vein,Vein, Hepatic,Veins, Hepatic
D006526 Hepatitis C INFLAMMATION of the LIVER in humans caused by HEPATITIS C VIRUS, a single-stranded RNA virus. Its incubation period is 30-90 days. Hepatitis C is transmitted primarily by contaminated blood parenterally and is often associated with transfusion and intravenous drug abuse. However, in a significant number of cases, the source of hepatitis C infection is unknown. Hepatitis, Viral, Non-A, Non-B, Parenterally-Transmitted,Parenterally-Transmitted Non-A, Non-B Hepatitis,PT-NANBH,Parenterally Transmitted Non A, Non B Hepatitis
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

N Afdhal, and G T Everson, and J L Calleja, and G W McCaughan, and J Bosch, and D M Brainard, and J G McHutchison, and S De-Oertel, and D An, and M Charlton, and K R Reddy, and T Asselah, and E Gane, and M P Curry, and X Forns
Effect of sustained viral response on hepatic venous pressure gradient in hepatitis C-related cirrhosis.
August 2007, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association,
N Afdhal, and G T Everson, and J L Calleja, and G W McCaughan, and J Bosch, and D M Brainard, and J G McHutchison, and S De-Oertel, and D An, and M Charlton, and K R Reddy, and T Asselah, and E Gane, and M P Curry, and X Forns
Hepatic venous pressure gradient: Inaccurately estimates portal venous pressure gradient in alcoholic cirrhosis and portal hypertension.
November 2023, World journal of gastrointestinal surgery,
N Afdhal, and G T Everson, and J L Calleja, and G W McCaughan, and J Bosch, and D M Brainard, and J G McHutchison, and S De-Oertel, and D An, and M Charlton, and K R Reddy, and T Asselah, and E Gane, and M P Curry, and X Forns
Correlation between hepatic venous pressure gradient and portal venous pressure gradient in hepatitis B cirrhosis with different hepatic veins anatomy.
October 2022, European journal of radiology,
N Afdhal, and G T Everson, and J L Calleja, and G W McCaughan, and J Bosch, and D M Brainard, and J G McHutchison, and S De-Oertel, and D An, and M Charlton, and K R Reddy, and T Asselah, and E Gane, and M P Curry, and X Forns
The role of hepatic venous pressure gradient in hepatitis C virus compensated cirrhosis.
December 2007, Gastroenterology,
N Afdhal, and G T Everson, and J L Calleja, and G W McCaughan, and J Bosch, and D M Brainard, and J G McHutchison, and S De-Oertel, and D An, and M Charlton, and K R Reddy, and T Asselah, and E Gane, and M P Curry, and X Forns
Wedged hepatic venous pressure adequately reflects portal pressure in hepatitis C virus-related cirrhosis.
December 1999, Hepatology (Baltimore, Md.),
N Afdhal, and G T Everson, and J L Calleja, and G W McCaughan, and J Bosch, and D M Brainard, and J G McHutchison, and S De-Oertel, and D An, and M Charlton, and K R Reddy, and T Asselah, and E Gane, and M P Curry, and X Forns
Hepatic venous pressure gradient determination in patients with hepatitis C virus-related and alcoholic cirrhosis.
October 2003, European journal of gastroenterology & hepatology,
N Afdhal, and G T Everson, and J L Calleja, and G W McCaughan, and J Bosch, and D M Brainard, and J G McHutchison, and S De-Oertel, and D An, and M Charlton, and K R Reddy, and T Asselah, and E Gane, and M P Curry, and X Forns
[Comparison of Doppler ultrasonography and hepatic venous pressure gradient in assessing portal hypertension in liver cirrhosis].
September 2002, Taehan Kan Hakhoe chi = The Korean journal of hepatology,
N Afdhal, and G T Everson, and J L Calleja, and G W McCaughan, and J Bosch, and D M Brainard, and J G McHutchison, and S De-Oertel, and D An, and M Charlton, and K R Reddy, and T Asselah, and E Gane, and M P Curry, and X Forns
Hepatic venous pressure gradient in the assessment of portal hypertension before liver resection in patients with cirrhosis.
June 2012, The British journal of surgery,
N Afdhal, and G T Everson, and J L Calleja, and G W McCaughan, and J Bosch, and D M Brainard, and J G McHutchison, and S De-Oertel, and D An, and M Charlton, and K R Reddy, and T Asselah, and E Gane, and M P Curry, and X Forns
[Risk factors of clinically significant portal hypertension in patients with compensated liver cirrhosis based on hepatic venous pressure gradient].
October 2021, Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology,
N Afdhal, and G T Everson, and J L Calleja, and G W McCaughan, and J Bosch, and D M Brainard, and J G McHutchison, and S De-Oertel, and D An, and M Charlton, and K R Reddy, and T Asselah, and E Gane, and M P Curry, and X Forns
Comparison of Doppler ultrasonography and the hepatic venous pressure gradient in assessing portal hypertension in liver cirrhosis.
April 2003, Journal of gastroenterology and hepatology,
Copied contents to your clipboard!